Print
XClose
Press Information Bureau
Government of India
PIB Headquarters
14 DEC 2021 6:59PM by PIB Delhi
PIB’S BULLETIN ON COVID-19

https://static.pib.gov.in/WriteReadData/userfiles/image/image0020FX3.png

https://static.pib.gov.in/WriteReadData/userfiles/image/image001BPSF.jpg

  •  Over 134 cr vaccine doses have been administered so far under Nationwide Vaccination Drive
  • India's Active caseload currently stands at 88,993; lowest in 563 days
  • Active cases account for less than 1% of total cases, currently at 0.26%; Lowest since March 2020
  • Recovery Rate currently at 98.37%; Highest since March 2020
  • 7,995 recoveries in the last 24 hours increases Total Recoveries to 3,41,38,763
  • 5,784 new cases in the last 24 hours, lowest in 571 days
  • Daily positivity rate (0.58%) less than 2% for last 71 days
  • Weekly Positivity Rate (0.68%) less than 1% for last 30 days
  • 65.76 cr Total Tests conducted so far

       #Unite2FightCorona                                                                                    #IndiaFightsCorona

 

 

 

 

PRESS INFORMATION BUREAU

MINISTRY OF INFORMATION & BROADCASTING

GOVERNMENT OF INDIA

*****  

Image

 

Image

 

 

India’s Cumulative COVID-19 Vaccination Coverage exceeds 134 Cr

Nearly 67 Lakh doses administered in the last 24 hours

Recovery Rate currently at 98.37% is highest since March 2020

5,784 New Cases reported in the last 24 hours


India's Active Caseload (88,993) is lowest in 563 days

Weekly Positivity Rate (0.68%) less than 1% for last 30 days

 

India’s Cumulative COVID-19 Vaccination Coverage has exceeded 134Cr today afternoon. This has been achieved through 1,40,27,706 sessions.

The break-up of the cumulative figure as per the provisional report till 7 am today include:

 

 

HCWs

1st Dose

1,03,85,716

2nd Dose

96,07,316

 

FLWs

1st Dose

1,83,83,175

2nd Dose

1,67,05,166

 

Age Group 18-44 years

1st Dose

47,99,75,178

2nd Dose

27,39,51,712

 

Age Group 45-59 years

1st Dose

18,99,59,003

2nd Dose

13,45,40,063

 

Over 60 years

1st Dose

11,87,51,430

2nd Dose

8,65,53,818

Total

1,33,88,12,577

 

The recovery of 7,995 patients in the last 24 hours has increased the cumulative tally of recovered patients (since the beginning of the pandemic) to 3,41,38,763.

Consequently, India’s recovery rate stands at 98.37%, highest since March 2020.

https://static.pib.gov.in/WriteReadData/userfiles/image/image002B14W.jpg

Sustained and collaborative efforts by the Centre and the States/UTs continue the trend of less than 15,000 Daily New Cases that is being reported for last 47days now.

5,784 new cases were reported in the last 24 hours. This is lowest in 571 days.

 https://static.pib.gov.in/WriteReadData/userfiles/image/image003UOPT.jpg

India’s Active Caseload presently at 88,993 is lowest in 563 days. Active cases constitute 0.26% of the country's total Positive Cases, which is lowest since March 2020.

https://static.pib.gov.in/WriteReadData/userfiles/image/image004H53P.jpg

 

The testing capacity across the country continues to be expanded. The last 24 hours saw a total of 9,50,482 tests being conducted. India has so far conducted over 65.76 Cr (65,76,62,933) cumulative tests.

While testing capacity has been enhanced across the country, Weekly Positivity Rate at 0.68% remains less than 1% for the last 30 days now. The Daily Positivity rate reported to be0.58%. The daily Positivity rate has remained below2% for last 71 days and below 3% for 106 consecutive days now.

https://static.pib.gov.in/WriteReadData/userfiles/image/image005WNXY.jpg

https://www.pib.gov.in/PressReleasePage.aspx?PRID=1781176

 

Update on COVID-19 Vaccine Availability in States/UTs

More than 140.28 Crore vaccine doses provided to States/UTs

More than 17.06 Crore balance and unutilized vaccine doses still available with States/UTs

 

The Union Government is committed to accelerating the pace and expanding the scope of COVID-19 vaccination throughout the country. The nationwide COVID 19 vaccination started on 16th January 2021. The new phase of universalization of COVID-19 vaccination commenced from 21st June 2021. The vaccination drive has been ramped up through availability of more vaccines, advance visibility of vaccine availability to States and UTs for enabling better planning by them, and streamlining the vaccine supply chain.

As part of the nationwide vaccination drive, Government of India has been supporting the States and UTs by providing them COVID Vaccines free of cost. In the new phase of the universalization of the COVID19 vaccination drive, the Union Government will procure and supply (free of cost) 75% of the vaccines being produced by the vaccine manufacturers in the country to States and UTs.

 

VACCINE DOSES

 

(As on 14th December, 2021)

SUPPLIED

1,40,38,75,650

BALANCE AVAILABLE  

17,06,13,661

More than 140.38crore (1,40,38,75,650) vaccine doses have been provided to States/UTs so far through Govt of India (free of cost channel) and through direct state procurement category.

More than17.06Cr (17,06,13,661) balance and unutilized COVID Vaccine doses are still available with the States/UTs to be administered.

https://www.pib.gov.in/PressReleasePage.aspx?PRID=1781171

 

Update on COVID-19 Vaccine Manufacturing Capacity
 

ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant) (COVISHIELD) is manufactured by M/s Serum Institute of India Pvt., Ltd., Pune, while the Whole Virion Inactivated Corona Virus Vaccine (COVAXIN) is manufactured by M/s Bharat Biotech International Limited, Hyderabad.

As communicated by the M/s Serum Institute of India, the current monthly vaccine production capacity of Covishield is approx. 250-275 Million doses per month.

Further, as communicated by M/s Bharat Biotech International Limited, Hyderabad, the current monthly vaccine production capacity of Covaxin is approx. 50-60 Million doses/month. Both companies have achieved close to 90% of present production capacity.

Moreover, as per the provisions of New Drugs and Clinical Trials Rules, 2019 under Drugs and Cosmetics Act, 1940 and in light of urgent need due to COVID pandemic in the country, CDSCO has granted permissions to following COVID-19 vaccines other than COVAXIN & COVISHIELD for prevention of COVID-19 for restricted use in emergency situation:

Permission For Manufacture of COVID-19 vaccines:

  1. Gam-COVID-Vac Combined vector vaccine [SPUTNIK-V] manufactured by M/s Ra (biologicals), Panacea Biotec Ltd., New Delhi using imported Ready to Fill (RTF) bulk from M/s Generium JSC, Russia on 02.07.2021.
  2. Novel Corona Virus 2019-nCoV vaccine [ZyCoV-D] manufactured by M/s Cadila Healthcare Limited, Ahmedabad on 20.08.2021.
  3. Ad26.COV2-S (recombinant) COVID-19 Vaccine manufactured by M/s Biological E limited, Hyderabad using imported bulk of M/s Johnson & Johnson Pvt. Ltd on 18.08.2021.
  4. Gam-COVID-Vac Combined vector vaccine [Sputnik–V] manufactured under technology transfer from M/s RDIF, Russia by M/s Hetero Biopharma Limited, Hyderabad on 07.10.2021.

https://www.pib.gov.in/PressReleasePage.aspx?PRID=1781267

 

Update on Availability of Ventilators across the country
 

In order to ensure availability of Ventilators across the country for management of COVID-19 pandemic, Ministry of Health and Family Welfare ordered procurement of Ventilators centrally for supplying to the States/UTs based on the demand received from the States/UTs. The States have been provided with extensive training on operation of these ventilators and more than 19,000 Doctors and Para-medical workers have been trained on them. States have been advised to ensure that the ventilators are kept fully functional at all times. They have also been advised to ensure maintenance and up-keep of ventilators, preparedness of hospital infrastructure including optimum oxygen pressure in medical Gas pipeline Systems, sufficient availability of consumables for ventilators and operation of these ventilators by the trained manpower.

https://www.pib.gov.in/PressReleasePage.aspx?PRID=1781271

 

Tweet Links

 

 

*********

AS